The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I trial of ALKS 4230, an engineered cytokine activator of NK and effector T cells, in patients with advanced solid tumors.
 
Ulka N. Vaishampayan
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Exelixis; Genentech; Janssen; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Novartis; Pfizer
Speakers' Bureau - Astellas Pharma; Bayer; Bristol-Myers Squibb; Exelixis; Genentech/Roche; Novartis; Pfizer; Sanofi
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Exelixis; Novartis; Pfizer
 
Marc S. Ernstoff
Stock and Other Ownership Interests - GE Healthcare
Consulting or Advisory Role - Celyad; Omniseq
Research Funding - Alkermes; Altor BioScience; Bristol-Myers Squibb; Merck
 
Vamsidhar Velcheti
Honoraria - Bristol-Myers Squibb; Foundation Medicine; Genentech/Roche; Merck; Novartis
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Clovis Oncology; Foundation Medicine; Genentech; Genoptix; Merck
Research Funding - Alkermes (Inst); Altor BioScience (Inst); Atreca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech (Inst); Genoptix (Inst); Heat Biologics (Inst); Leap Therapeutics (Inst); Merck (Inst); NantWorks (Inst); OncoPlex Diagnostics (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Eisai
 
Christopher J. Hoimes
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Foundation Medicine; Prometheus
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche
Research Funding - Merck Sharp & Dohme
 
Mayer N. Fishman
Consulting or Advisory Role - Eisai; Exelixis; Pfizer
Speakers' Bureau - Exelixis; Pfizer
Research Funding - Acceleron Pharma; Alkermes; AstraZeneca; Bristol-Myers Squibb; Eisai; Pfizer; Prometheus; Roche/Genentech
 
Daniel C. Cho
Consulting or Advisory Role - Bristol-Myers Squibb; Exelixis; Genentech; Pfizer; Prometheus
Expert Testimony - Roxane Laboratories
 
David F. McDermott
Consulting or Advisory Role - Alexion Pharmaceuticals; Array BioPharma; Bristol-Myers Squibb; Eisai; exelixis; Genentech/Roche; Merck; Novartis; Pfizer; X4 Pharma
Research Funding - Prometheus (Inst)
 
Michael R. Kurman
Consulting or Advisory Role - Alkermes
 
Juan Alvarez
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes; Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Regeneron
Patents, Royalties, Other Intellectual Property - Alkermes
 
Lei Sun
Employment - Alkermes
Stock and Other Ownership Interests - Alkermes
Research Funding - Alkermes
 
William Slichenmyer
Employment - Alacrita; Alkermes
Consulting or Advisory Role - Akebia Therapeutics; Alchemia; Alexion Pharmaceuticals; Array BioPharma; Checkmate Pharmaceuticals; Infinity Pharmaceuticals; Pyramid Biosciences; Viralytics; X4 Pharma
 
Sean Rossi
Employment - Alkermes